AUD 0.06
(-1.64%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 12.63 Million AUD | -4.07% |
2023 | 13.17 Million AUD | 9.27% |
2022 | 12.05 Million AUD | 14.43% |
2021 | 10.53 Million AUD | -44.46% |
2020 | 18.96 Million AUD | 47.59% |
2019 | 12.84 Million AUD | -16.47% |
2018 | 15.38 Million AUD | 48.17% |
2017 | 10.38 Million AUD | 72.07% |
2016 | 6.03 Million AUD | 123.43% |
2015 | 2.7 Million AUD | 520.21% |
2014 | 435.37 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 11.67 Million AUD | 0.0% |
2024 Q4 | 12.63 Million AUD | 0.0% |
2024 FY | 12.69 Million AUD | -3.58% |
2023 FY | 13.17 Million AUD | 9.27% |
2023 Q4 | 13.17 Million AUD | 0.0% |
2023 Q2 | 11.47 Million AUD | 0.0% |
2022 Q4 | 12.05 Million AUD | 0.0% |
2022 FY | 12.05 Million AUD | 14.43% |
2022 Q2 | 10.69 Million AUD | 0.0% |
2021 FY | 10.53 Million AUD | -44.46% |
2021 Q4 | 10.53 Million AUD | 0.0% |
2021 Q2 | 17.65 Million AUD | 0.0% |
2020 Q2 | 17.94 Million AUD | 0.0% |
2020 FY | 18.96 Million AUD | 47.59% |
2020 Q4 | 18.96 Million AUD | 0.0% |
2019 Q2 | 13.7 Million AUD | 0.0% |
2019 Q4 | 12.84 Million AUD | 0.0% |
2019 FY | 12.84 Million AUD | -16.47% |
2018 Q2 | 9.34 Million AUD | 0.0% |
2018 FY | 15.38 Million AUD | 48.17% |
2018 Q4 | 15.38 Million AUD | 0.0% |
2017 Q2 | 10.6 Million AUD | 0.0% |
2017 Q4 | 10.38 Million AUD | 0.0% |
2017 FY | 10.38 Million AUD | 72.07% |
2016 Q4 | 6.03 Million AUD | 0.0% |
2016 Q2 | 4.6 Million AUD | 0.0% |
2016 FY | 6.03 Million AUD | 123.43% |
2015 Q4 | 18.11 Million AUD | 0.0% |
2015 FY | 2.7 Million AUD | 520.21% |
2015 Q3 | 18.11 Million AUD | 0.0% |
2014 FY | 435.37 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 74.263% |
Adherium Limited | 3.4 Million AUD | -270.851% |
Aroa Biosurgery Limited | 14.77 Million AUD | 14.512% |
Atomo Diagnostics Limited | 1.29 Million AUD | -876.056% |
Anteris Technologies Ltd | 17.03 Million AUD | 25.853% |
Control Bionics Limited | 2.75 Million AUD | -357.82% |
CardieX Limited | 8.56 Million AUD | -47.554% |
Compumedics Limited | 22.14 Million AUD | 42.956% |
Cochlear Limited | 904.6 Million AUD | 98.603% |
CleanSpace Holdings Limited | 6.94 Million AUD | -81.791% |
Cyclopharm Limited | 13.65 Million AUD | 7.475% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -131.576% |
Nova Eye Medical Limited | 8.55 Million AUD | -47.732% |
HeraMED Limited | 1.5 Million AUD | -738.946% |
Imricor Medical Systems, Inc. | 25 Million AUD | 49.473% |
ImpediMed Limited | 6.24 Million AUD | -102.371% |
InhaleRx Limited | 911.41 Thousand AUD | -1286.199% |
LBT Innovations Limited | 5.5 Million AUD | -129.375% |
Neurotech International Limited | 314.69 Thousand AUD | -3914.63% |
OncoSil Medical Limited | 1.98 Million AUD | -537.439% |
PolyNovo Limited | 37.04 Million AUD | 65.894% |
Respiri Limited | 3.55 Million AUD | -255.489% |
SomnoMed Limited | 24.78 Million AUD | 49.016% |
Universal Biosensors, Inc. | 10.61 Million AUD | -19.048% |
Uscom Limited | 2.07 Million AUD | -509.286% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -356.611% |